In Depth 25 Jul 2024 The future of inflammatory bowel disease treatment: what is on the horizon? Ongoing clinical trials aim to address inflammatory bowel disease, which is caused by an overactive immune system that causes symptoms affecting the gut. July 25, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 11 Jul 2024 From data to discovery: Five bioinformatics companies you should know in 2024 Bioinformatics integrates computer technology to analyze biological data to boost R&D. Here are five companies at the top of their game in 2024. July 11, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 10 Jul 2024 Biotech’s battle against skeletal dysplasia: Ray of hope for children with rare genetic disorder As treatments for skeletal dysplasia are intended to alleviate painful symptoms, two drugs are battling out in the clinic to prove their effectiveness. July 10, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 28 Jun 2024 Going nuclear: radiopharmaceuticals funding sees surge in 2024 Emerging as a new class of drugs, radiopharmaceuticals are all the rage in cancer treatment research as biotechs nab major funding deals. June 28, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 27 Jun 2024 The 2024 drug approval list: Eight new treatments you should know about In this article, we take a look at eight much-anticipated drugs that have been approved by regulators so far this year. June 27, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 19 Jun 2024 MASH candidates make a splash after first drug approval The first drug to treat MASH, a potentially life-threatening liver disease, was approved this year. More recent advancements bring hope to patients. June 19, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 17 Jun 2024 Moving with the times: biopharma royalty deals on the rise A spate of royalty deals are changing the way certain biotechs press ahead. This trend seems to be an alternative to traditional biopharma fundraising. June 17, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 10 Jun 2024 ASCO 2024: The latest advances in oncology clinical trials Biotechs from all over the country as well as other parts of the world showcased recent pipeline advancements in oncology clinical trials at ASCO 2024. June 10, 2024 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 6 Jun 2024 CRISPR: A promising path to treating blindness Rigorous research, which has been going on for more than a decade now, suggests that CRISPR could treat genetic diseases including blindness. June 6, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 5 Jun 2024 Evolving standards of care: new treatments for cervical cancer New treatments for cervical cancer aim to broaden therapeutic options, and improve current standards of care for patients. June 5, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 31 May 2024 Biotech career fairs in the U.S. you don’t want to miss Biotech career fairs are held to connect talent with professionals and recruiters. Here are six popular events that take place annually in the U.S. May 31, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 30 May 2024 Covalent biologics: a new class of drugs on the horizon The field of covalent biologics has made headway recently, as the only biotech in the space has bagged $100 million to move its pipeline to the clinic. May 30, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email